Meibomian gland dysfunction – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:06:16 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Meibomian gland dysfunction – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness and Safety of Hydrocortisone Sodium Phosphate for Patients with Dry Eye and Moderate Meibomian Gland Dysfunction https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-hydrocortisone-sodium-phosphate-for-patients-with-dry-eye-and-moderate-meibomian-gland-dysfunction/ Wed, 29 Apr 2026 14:22:53 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-hydrocortisone-sodium-phosphate-for-patients-with-dry-eye-and-moderate-meibomian-gland-dysfunction/ This clinical trial is focused on studying the effects of a treatment for Dry Eye Disease associated with moderate Meibomian Gland Dysfunction. The treatment being tested includes the use of eye drops containing hydrocortisone sodium phosphate, which is a type of medication that helps reduce inflammation. The study will also involve the use of lid hygiene practices, artificial tears, and a medical device called the BlephaEyeBag, which is a reusable eye bag that can be heated in a microwave.

The purpose of the study is to evaluate the effectiveness and safety of this treatment combination. Participants will be monitored over a period of time to observe changes in their symptoms and any potential side effects. The study will track changes in symptoms from the start of the study to two weeks later, and will also look at the levels of certain proteins in tears that are related to inflammation. Additionally, the study will monitor the pressure inside the eyes at various points to ensure safety.

Participants will be asked to follow the treatment plan and attend several follow-up visits over a few months. During these visits, researchers will assess the symptoms of dry eye and meibomian gland dysfunction, as well as any changes in vision or eye health. The study aims to provide valuable information on how well this treatment works and its safety for people with these eye conditions.

]]>